Characterization of antigenic determinants in ApxIIA exotoxin capable of inducing protective immunity to Actinobacillus pleuropneumoniae challenge

Immunological Investigations

Volumn 40, Issue 5, 2011, Pages 465-480

  Seo, Ki Weon ^a   Kim, Dong Heon ^a   Kim, Ah Hyun ^b   Yoo, Han Sang ^c   Lee, Kyung Yeol ^a   Jang, Yong Suk ^a  

^a Chonbuk National University   (South Korea)

^b Korea Minjok Leadership Academy   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Actinobacillus pleuropneumoniae; Epitope; Immune response; Vaccine

Indexed keywords

APXII TOXIN, BACTERIA; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; EXOTOXIN; HEMOLYSIN; RECOMBINANT PROTEIN;

ACTINOBACILLUS INFECTION; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD; GENETICS; IMMUNIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MORTALITY; MOUSE;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; EXOTOXINS; HEMOLYSIN PROTEINS; IMMUNIZATION; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS;

EID: 80053301211     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2011.558151     Document Type: Article

References (56)

1. Anderson, C., Potter, A. A., Gerlach, G. F. (1991). Isolation and molecular characterization of spontaneously occurring cytolysin-negative mutants of Actinobacillus pleuropneumoniae serotype 7. Infect. Immun. 59:4110-4116.
2. Beaudet, R., McSween, G., Boulay, G., Rousseau, P., Bisaillon, J. G., Descoteaux, J. P., Ruppanner, R. (1994). Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination. Vet. Microbiol. 39:71-81. (Pubitemid 24107598)
3. Bosse, J. T., Janson, H., Sheehan, B. J., Beddek, A. J., Rycroft, A. N., Kroll, J. S., Langford, P. R. (2002). Actinobacillus pleuropneumoniae: pathobiology and pathogenesis of infection. Microbes Infect. 4:225-235. (Pubitemid 34183498)
4. Chiang, C. H., Huang, W. F., Huang, L. P., Lin, S. F., Yang, W. J. (2009). Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model. Vaccine 27:4565-4570.
5. Coghlan, A., Wolfe, K. H. (2000). Relationship of codon bias to mRNA concentration and protein length in Saccharomyces cerevisiae. Yeast 16:1131-1145.
6. Dubreuil, J. D., Jacques, M., Mittal, K. R., Gottschalk, M. (2000). Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity. Anim. Health Res. Rev. 1:73-93.
7. Duret, L., Mouchiroud, D. (1999). Expression pattern and, surprisingly, gene length shape codon usage in Caenorhabditis, Drosophila, and Arabidopsis. Proc. Natl. Acad. Sci. USA 96:4482-4487. (Pubitemid 29190362)
8. Frey, J. (1995). Virulence in Actinobacillus pleuropneumoniae and RTX toxins. Trends Microbiol. 3:257-261.
9. Freytag, L. C., Clements, J. D. (2005). Mucosal adjuvants. Vaccine 23:1804-1813. (Pubitemid 40331849)
10. Fuller, T. E., Martin, S., Teel, J. F., Alaniz, G. R., Kennedy, M. J., Lowery, D. E. (2000). Identification of Actinobacillus pleuropneumoniae virulence genes using signaturetagged mutagenesis in a swine infection model. Microb. Pathog. 29:39-51.
11. Galao, R. P., Scheller, N., Alves-Rodrigues, I., Breinig, T., Meyerhans, A., Diez, J. (2007). Saccharomyces cerevisiae: A versatile eukaryotic system in virology. Microb. Cell Fact 6:32.
12. Haesebrouck, F., Chiers, K., Van Overbeke, I., Ducatelle, R. (1997). Actinobacillus pleuropneumoniae infections in pigs: the role of virulence factors in pathogenesis and protection. Vet. Microbiol. 58:239-249. (Pubitemid 28026787)
13. Harakuni, T., Sugawa, H., Komesu, A., Tadano, M., Arakawa, T. (2005). Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect. Immun. 73:5654-5665. (Pubitemid 41193001)
14. Hatfield, G. W., Roth, D. A. (2007). Optimizing scaleup yield for protein production: Computationally optimized DNA assembly (CODA) and translation engineering. Biotechnol. Annu. Rev. 13:27-42. (Pubitemid 47387122)
15. Ingvarsson, P. K. (2007). Gene expression and protein length influence codon usage and rates of sequence evolution in Populus tremula. Mol. Biol. Evol. 24:836-844. (Pubitemid 46355807)
16. Inzana, T. J., Mathison, B. (1987). Serotype specificity and immunogenicity of the capsular polymer of Haemophilus pleuropneumoniae serotype 5. Infect. Immun. 55:1580-1587. (Pubitemid 17084146)
17. Jacques, M., Belanger, M., Roy, G., Foiry, B. (1991). Adherence of Actinobacillus pleuropneumoniae to porcine tracheal epithelial cells and frozen lung sections. Vet. Microbiol. 27:133-143.
18. Jana, S., Deb, J. K. (2005). Strategies for efficient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol 67:289-298. (Pubitemid 40684730)
19. Jarma, E., Corradino, G., Regassa, L. B. (2004). Anaerobiosis, growth phase and Actinobacillus pleuropneumoniae RTX toxin production. Microb Pathog 37:29-33. (Pubitemid 38759616)
20. Jarma, E., Regassa, L. B. (2004). Growth phase mediated regulation of the Actinobacillus pleuropneumoniae ApxI and ApxII toxins. Microb Pathog 36:197-203. (Pubitemid 38328456)
21. Kim, J. M., Jung, D. I., Eom, Y. J., Park, S. M., Yoo, H. S., Jang, Y. S., Yang, M. S., Kim, D. H. (2010). Surface-displayed expression of a neutralizing epitope of ApxIIA exotoxin in Saccharomyces cerevisiae and oral administration of it for protective immune responses against challenge by Actinobacillus pleuropneumoniae. Biosci. Biotechnol. Biochem. 74:1362-1367.
22. Kunkel, E. J., Butcher, E. C. (2003). Plasma-cell homing. Nat. Rev. Immunol. 3:822-829. (Pubitemid 37328660)
23. Kurland, C. G. (1991). Codon bias and gene expression. FEBS Lett. 285:165-169.
24. Lally, E. T., Hill, R. B., Kieba, I. R., Korostoff, J. (1999). The interaction between RTX toxins and target cells. Trends Microbiol. 7:356-361. (Pubitemid 29421660)
25. Lee, K. Y., Kim, D. H., Kang, T. J., Kim, J., Chung, G. H., Yoo, H. S., Arntzen, C. J., Yang, M. S., Jang, Y. S. (2006). Induction of protective immune responses against the challenge of ctinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. FEMS Immunol. Med. Microbiol. 48:381-389. (Pubitemid 44736577)
26. Lemos, B., Bettencourt, B. R., Meiklejohn, C. D., Hartl, D. L. (2005). Evolution of proteins and gene expression levels are coupled in Drosophila and are independently associated with mRNA abundance, protein length, and number of protein-protein interactions. Mol. Biol. Evol. 22:1345-1354. (Pubitemid 40577773)
27. Liljeqvist, S., Stahl, S., Andreoni, C., Binz, H., Uhlen, M., Murby, M. (1997). Fusions to the cholera toxin B subunit: influence on pentamerization and GM1 binding. J. Immunol. Meth. 210:125-135. (Pubitemid 28266557)
28. Liu, J., Chen, X., Tan, C., Guo, Y., Chen, Y., Fu, S., Bei, W., Chen, H. (2009). In vivo induced RTX toxin ApxIVA is essential for the full virulence of Actinobacillus pleuropneumoniae. Vet. Microbiol. 137:282-289.
29. Maier, E., Reinhard, N., Benz, R., Frey, J. (1996). Channel-forming activity and channel size of the RTX toxins ApxI, ApxII, and ApxIII of Actinobacillus pleuropneumoniae. Infect. Immun. 64:4415-4423. (Pubitemid 26357038)
30. Makrides, S. C. (1996). Strategies for achieving high-level expression of genes in Escherichia coli. Microbiol. Rev. 60:512-538. (Pubitemid 26303477)
31. Marais, G., Duret, L. (2001). Synonymous codon usage, accuracy of translation, and gene length in Caenorhabditis elegans. J. Mol. Evol. 52:275-280.
32. Mason, H. S., Warzecha, H., Mor, T., Arntzen, C. J. (2002). Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol. Med. 8:324-329. (Pubitemid 34733385)
33. Min, K., Chae, C. (1999). Serotype and apx genotype profiles of Actinobacillus pleuropneumoniae field isolates in Korea. Vet. Rec. 145:251-254. (Pubitemid 129544103)
34. Moriyama, E. N., Powell, J. R. (1998). Gene length and codon usage bias in Drosophila melanogaster, Saccharomyces cerevisiae and Escherichia coli. Nucl. Acids Res. 26:3188-3193. (Pubitemid 28288917)
35. Nochi, T., Takagi, H., Yuki, Y., Yang, L., Masumura, T., Mejima, M., Nakanishi, U., Matsumura, A., Uozumi, A., Hiroi, T., et al. (2007). Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination. Proc. Natl. Acad. Sci. USA 104:10986-10991. (Pubitemid 47175213)
36. Prideaux, C. T., Lenghaus, C., Krywult, J., Hodgson, A. L. (1999). Vaccination and protection of pigs against pleuropneumonia with a vaccine strain of Actinobacillus pleuropneumoniae produced by site-specific mutagenesis of the ApxII operon. Infect Immun 67:1962-1966. (Pubitemid 29144422)
37. Prideaux, C. T., Pierce, L., Krywult, J., Hodgson, A. L. (1998). Protection of mice against challenge with homologous and heterologous serovars of Actinobacillus pleuropneumoniae after live vaccination. Curr. Microbiol. 37:324-332. (Pubitemid 28563409)
38. Ramjeet, M., Deslandes, V., Goure, J., Jacques, M. (2008). Actinobacillus pleuropneumoniae vaccines: from bacterins to new insights into vaccination strategies. Anim. Health Res. Rev. 9:25-45.
39. Reimer, D., Frey, J., Jansen, R., Veit, H. P., Inzana, T. J. (1995). Molecular investigation of the role of ApxI and ApxII in the virulence of Actinobacillus pleuropneumoniae serotype 5. Microb. Pathog. 18:197-209.
40. Rice, J., Ainley, W. M., Shewen, P. (2005). Plant-made vaccines: biotechnology and immunology in animal health. Anim. Health Res. Rev. 6:199-209.
41. Rycroft, A. N., Cullen, J. M. (1990). Complement resistance in Actinobacillus (Haemophilus) pleuropneumoniae infection of swine. Am. J. Vet. Res. 51:1449-1453.
42. Schaller, A., Kuhn, R., Kuhnert, P., Nicolet, J., Anderson, T. J., MacInnes, J. I., Segers, R. P., Frey, J. (1999). Characterization of apxIVA, a new RTX determinant of Actinobacillus pleuropneumoniae. Microbiology 145(Pt. 8):2105-2116. (Pubitemid 29396941)
43. Seah, J. N., Frey, J., Kwang, J. (2002). The N-terminal domain of RTX toxin ApxI of Actinobacillus pleuropneumoniae elicits protective immunity in mice. Infect. Immun. 70:6464-6467. (Pubitemid 35192742)
44. Shin, S. J., Bae, J. L., Cho, Y. W., Lee, D. Y., Kim, D. H., Yang, M. S., Jang, Y. S., Yoo, H. S. (2005). Induction of antigen-specific immune responses by oral vaccination with Saccharomyces cerevisiae expressing Actinobacillus pleuropneumoniae ApxIIA. FEMS Immunol. Med. Microbiol. 43:155-164. (Pubitemid 40170284)
45. Shin, S. J., Cho, Y.-W., Yoo, H. S. (2003). Cloning, sequencing and expression of apxIA, IIA, IIIA of Actinobacillus pleuropneumoniae isolated in Korea. Kor. J. Vet. Res. 43:7.
46. Silin, D. S., Lyubomska, O. V., Jirathitikal, V., Bourinbaiar, A. S. (2007). Oral vaccination: where we are? Expert Opin. Drug Deliv. 4:323-340. (Pubitemid 47260194)
47. Silva, A. J., Eko, F. O., Benitez, J. A. (2008). Exploiting cholera vaccines as a versatile antigen delivery platform. Biotechnol. Lett. 30:571-579.
48. Simerska, P., Moyle, P. M., Olive, C., Toth, I. (2009). Oral vaccine delivery-New strategies and technologies. Curr. Drug Deliv. 6:347-358.
49. Spangler, B. D. (1992). Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647.
50. Streatfield, S. J. (2006). Mucosal immunization using recombinant plant-based oral vaccines. Methods 38:150-157. (Pubitemid 43163476)
51. Streatfield, S. J., Howard, J. A. (2003). Plant-based vaccines. Int. J. Parasitol. 33:479-493. (Pubitemid 36638531)
52. Tascon, R. I., Vazquez-Boland, J. A., Gutierrez-Martin, C. B., Rodriguez-Barbosa, I., Rodriguez-Ferri, E. F. (1994). The RTX haemolysins ApxI and ApxII are major virulence factors of the swine pathogen Actinobacillus pleuropneumoniae: evidence from mutational analysis. Mol. Microbiol. 14:207-216.
53. Thwaits, R. N., Kadis, S. (1993). Purification of surface-exposed integral outer membrane proteins of Actinobacillus pleuropneumoniae and their role in opsonophagocytosis. Am. J. Vet. Res. 54:1462-1470.
54. Warringer, J., Blomberg, A. (2006). Evolutionary constraints on yeast protein size. BMC Evol. Biol. 6:61.
55. Welch, R. A., Bauer, M. E., Kent, A. D., Leeds, J. A., Moayeri, M., Regassa, L. B., Swenson, D. L. (1995). Battling against host phagocytes: the wherefore of the RTX family of toxins? Infect. Agents Dis. 4:254-272. (Pubitemid 26002079)
56. Yin, J., Li, G., Ren, X., Herrler, G. (2007). Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes. J. Biotechnol. 127:335-347. (Pubitemid 44827384)